Table 3.
An in-depth analysis of AgNPs and their potential uses.
Application Area | Description | Clinical Insights | Setting | References |
---|---|---|---|---|
Antibacterial | AgNPs are used in coatings and textiles to inhibit bacterial infections, especially against antibiotic-resistant strains. | AgNPs, in combination with antibiotics, enhance effectiveness against multidrug-resistant bacterial infections. | In vitro | [235,236,237,238,239,240] |
Antiviral | AgNPs demonstrate antiviral capabilities against viruses such as coronaviruses, HIV-1, influenza, herpes simplex, and hepatitis B. | AgNPs act as virucidal agents and show synergistic effects with antiviral drugs such as oseltamivir against H1N1. | In vitro | [215,241,242,243] |
Antibiofilm | AgNPs are incorporated into coatings to prevent biofilm formation and disrupt established biofilms. | Effective against antibiotic-resistant bacteria biofilms, such as those formed by Staphylococcus aureus and Escherichia coli. | In vitro | [200,244,245,246,247,248] |
Antifungal | AgNPs exhibit antifungal properties against various fungi, including those causing plant diseases and infections in immunocompromised individuals. | Used to treat drug-resistant fungal infections and enhance the effectiveness of antifungal treatments. | In vitro | [38,40,246,247,249,250,251,252,253] |
Antiparasitic | AgNPs show potential against parasites such as malaria vectors, leishmaniasis, and Acanthamoeba. | Demonstrate efficacy against parasites at different lifecycle stages when produced using various green synthesis methods. | In vitro | [254,255,256,257,258,259,260,261,262] |
Anticancer and Antitumor | AgNPs induce cytotoxicity in cancer cells and enhance targeted drug delivery. | Used alone or with other anticancer drugs, they increase the therapeutic efficacy of treatments such as chemotherapy. | In vitro | [5,263,264,265,266] |
Food Industry | AgNPs are used in the food industry for their antibacterial properties, including food packaging, coatings, and films to prevent food spoilage and contamination. | AgNPs enhance the antimicrobial properties of food packaging materials, helping to prevent the growth of drug-resistant bacteria in food products. | In vitro | [267,268,269,270,271,272] |
Drug Delivery | AgNPs improve drug stability and bioavailability, offering controlled release for enhanced treatment efficacy. | Can penetrate biological barriers, such as the blood-brain barrier, facilitating targeted drug delivery. | In vitro | [5,273] |
Medical Implants | AgNPs are used to coat medical implants, enhancing their antibacterial properties and longevity. | Reduce infection rates in implanted devices, show minimal cytotoxicity, and promote osseointegration. | In vitro | [274,275,276,277,278] |
Surface Coatings | AgNPs in surface coatings offer antibacterial properties and thermal enhancements, effectively fighting bacteria in air and water… | AgNPs enhance the antibacterial properties of surfaces, including porous titanium, and can modify surfaces for better microbial resistance. | In vitro | [99,279,280,281,282,283,284,285] |
Dentistry and dental industry | AgNPs are utilized in dental materials to prevent biofilm formation, crucial for oral health. | Improve antibacterial properties in various dental applications, supporting sterile environments. | In vitro and In vivo | [244,286,287,288,289] |